Special Issues
Cancers publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
PARPs, PAR and NAD Metabolism and Their Inhibitors in Cancer
Deadline: 31 December 2019
Cancer Immunotherapy Using Natural Killer Cells: Successes and Challenges of the Field
Deadline: 15 January 2020
Animal Models for Radiotherapy Research
Deadline: 17 January 2020
Photodynamic Therapy (PDT) in Oncology
Deadline: 31 January 2020
Pediatric Brain Tumor
Deadline: 31 January 2020
Risk Prediction and New Prophylaxis Strategies for Thromboembolism in Cancer
Deadline: 31 January 2020
New Insights into Cancer Vaccines and Immunotherapy
Deadline: 31 January 2020
Adrenocortical Carcinoma
Deadline: 31 January 2020
Acute Promyelocytic Leukemia
Deadline: 31 January 2020
Mitochondrial function and dysfunction in cancer and their potential as anti-cancer targets
Deadline: 29 February 2020
Targeted Therapies for Melanoma
Deadline: 29 February 2020
Estrogen Receptor (ER) Signalling Pathway in Cancers
Deadline: 29 February 2020
of 276

